01
01H.F HORIBA Ltd
- Market cap
- EUR 4.71B
- P/E
- 19.8x
- P/B
- 2.20x
- ROE
- 11.9%
- Dividend yield
- 1.80%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 01H.F undervalued?
Graham number01H.F trades 39.2% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
HORIBA Ltd fundamental analysis
No fundamental analysis for HORIBA Ltd yet.
HORIBA Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About HORIBA Ltd
HORIBA, Ltd., together with its subsidiaries, provides analytical and measurement solutions in Japan, Asia, the United States, and Europe. It operates in three segments: Energy and Environment; Bio and Healthcare; and Advanced Materials and Semiconductor. The company offers mobility products, including systems for emissions measurement, internal combustion engine testing, driveline and powertrain evaluation, brake testing, and wind tunnels; and energy and environment solutio…
Full company profileHORIBA Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
HORIBA Ltd annual financial statements (JPY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 170B | 195B | 211B | 200B | 187B | 224B | 270B | 291B | 317B | 333B | 360B |
| Gross Profit | 69.8B | 83.3B | 89.9B | 82.6B | 76.4B | 93.2B | 117B | 127B | 137B | 146B | 162B |
| Operating Income | 18.5B | 26.8B | 28.8B | 20.9B | 19.7B | 32.0B | 45.8B | 47.3B | 48.3B | 53.0B | 61.0B |
| EBITDA | - | 32.3B | 36.6B | 30.0B | 28.9B | 41.2B | 59.3B | 67.0B | 62.8B | 65.7B | 63.1B |
| Net Income | 13.0B | 16.3B | 22.3B | 15.5B | 13.2B | 21.3B | 34.1B | 40.3B | 33.6B | 37.1B | 43.6B |
| EPS | - | 386 | 529 | 367 | 313 | 505 | 807 | 953 | 801 | 883 | 1,038 |
| Balance Sheet | |||||||||||
| Total Assets | 240B | 266B | 278B | 315B | 328B | 372B | 417B | 449B | 482B | 518B | 543B |
| Total Liabilities | 106B | 115B | 116B | 144B | 149B | 167B | 176B | 165B | 167B | 170B | 178B |
| Shareholders' Equity | 133B | 151B | 162B | 172B | 179B | 204B | 241B | 284B | 315B | 349B | 365B |
| Cash & Short-term Investments | 52.3B | 59.0B | 63.6B | 95.6B | 115B | 135B | 140B | 133B | 144B | 162B | 169B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 15.9B | 28.3B | 19.5B | 26.6B | 32.3B | 35.3B | 34.0B | 16.7B | 40.3B | 54.4B | - |
| Capital Expenditure | 13.4B | 11.7B | 9.67B | 11.8B | 14.6B | 12.2B | 11.6B | 9.17B | 19.4B | 26.1B | 0.00 |
| Free Cash Flow | - | 16.3B | 9.26B | 13.7B | 17.2B | 22.7B | 21.9B | 7.48B | 20.9B | 28.2B | - |
| Ratios | |||||||||||
| ROE | 9.7% | 10.8% | 13.8% | 9.0% | 7.4% | 10.4% | 14.1% | 14.2% | 10.7% | 10.6% | 11.9% |
| ROA | 5.4% | 6.1% | 8.0% | 4.9% | 4.0% | 5.7% | 8.2% | 9.0% | 7.0% | 7.2% | 8.0% |
| Net Profit Margin | 7.6% | 8.3% | 10.6% | 7.7% | 7.0% | 9.5% | 12.6% | 13.9% | 10.6% | 11.1% | 12.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
HORIBA Ltd dividends
- Dividend yield
- 1.80%
- Forward dividend
- 1.95 EUR
- Payout ratio
- 30.5%
- Ex-dividend date
- Dec 29, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | JPY 11.3B | 270 | 30.5% |
| 2024 | JPY 12.2B | 291 | 36.4% |
| 2023 | JPY 11.0B | 260 | 27.2% |
| 2022 | JPY 6.96B | 165 | 20.4% |
| 2021 | JPY 4.64B | 110 | 21.8% |
| 2020 | JPY 4.64B | 110 | 35.2% |
| 2019 | EUR 6.11B | 145 | 39.5% |
| 2018 | EUR 5.31B | 126 | 23.8% |
| 2017 | EUR 4.00B | 95 | 24.6% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns HORIBA Ltd
- Insiders 9.34%
- Institutions 51.03%
- Public & others 39.63%
- Shares outstanding 42.0M
- Free float 34.4M
HORIBA Ltd company profile
- Company name
- HORIBA Ltd
- Ticker
- 01H.F
- ISIN
- JP3853000002
- Exchange
- Frankfurt Exchange
- Sector
- Technology
- Industry
- Electronic Equipment, Instruments & Components
- Employees
- 9,101
- Fiscal year end
- December
- Address
- 2 Miyanohigashi-cho, Kyoto, Japan, 601-8510
- Phone
- 81 75 313 8121
- Website
- horiba.com
About HORIBA Ltd
HORIBA, Ltd., together with its subsidiaries, provides analytical and measurement solutions in Japan, Asia, the United States, and Europe. It operates in three segments: Energy and Environment; Bio and Healthcare; and Advanced Materials and Semiconductor. The company offers mobility products, including systems for emissions measurement, internal combustion engine testing, driveline and powertrain evaluation, brake testing, and wind tunnels; and energy and environment solutions for water and liquid, industrial process, and energy. It also provides life science products comprising fluorescence spectroscopy, raman imaging and spectrometers, and particle characterization; healthcare solutions, which include vitro diagnostic systems for biological analysis, clinical chemistry, veterinary, hematology, and hemostasis; material analysis, such as elemental analysis, molecular and structural analysis, and surface analysis and thin film characterization; and semiconductor products. In addition, the company offers technology solutions comprising health care, fluid control, mass spectrometry, spectroscopy, microscopy and imaging, electrochemistry, physisorption, particle and element analysis, and surface plasmon resonance; and services, including analysis centers, calibration and certification, customer support, spare parts and consumables, testing and consulting, and product and technology training. Its products are used in arts, entertainment, and recreation; biopharma and pharma, biotechnology and biomedical; cosmetics; education, research and development, and government institution; energy solutions; food and beverage; healthcare; industrials; information technology; materials; mobility and transportation; waste management; and water applications. HORIBA, Ltd. was founded in 1945 and is headquartered in Kyoto, Japan.
HORIBA Ltd management
10- Mr. Atsushi HoribaChairman & Group CEO · born 1948
- Dr. Masayuki Adachi Ph.D.President & Director · born 1962
- Mr. Juichi SaitoExecutive Vice Chairman & Group COO · born 1958
- Mr. Hideyuki KoishiExecutive Corporate Officer · born 1963
- Mr. Koji KoyamaSenior MD, Group CFO, Head of Legal Affairs & Director · born 1969
- Hiroshi Nakamura Ph.D.Managing Executive Officer and GM of Technology Innovation Center & Development Division
- Mr. Takashi NaganoSenior Managing Executive Officer
- Mr. Yasuo YamashitaCorporate Officer & GM of General Administration Division
- Ken MiteraSenior Corporate Officer
- Dale PooleManaging Executive Officer